94631 ⎘
Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups - not condensed with other rings
AMPHIPHILIC COMPOUNDS FOR ATTENUATING NEUROTOXICITY OF AMYLOID-beta OLIGOMERS AND DIAGNOSTIC METHODS
#2BIODEGRADABLE LIPIDS AND FORMULATIONS FOR DELIVERY OF MRNA
#31,4-BIS-(2-HYDROXY-BENZYL)-1,4,7-TRIAZACYCLONONANE DERIVATIVES AND SIMILAR COMPOUNDS AS LIGANDS IN IRON(III) COMPLEXES FOR USE AS MRI CONTRAST AGENTS
#4NITROGEN-BRANCHED NON-LINEAR PEGYLATED LIPID CONTAINING A TERTIARY AMINE AND APPLICATION THEREOF
#52-PYRAZOLE ANILINES AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD
#6SYNTHESIS OF ESTER, CARBONATE, AND CARBAMATE-DERIVED NOVEL BIODEGRADABLE IONIZABLE LIPIDS FROM METHYL RICINOLEATE OR METHYL 12-HYDROXYSTEARATE AND ITS APPLICATIONS
#7PRE-TARGETING STRATEGIES FOR MOLECULAR IMAGING AND/OR RADIOIMMUNOTHERAPY
#8DIMERIZATION STRATEGIES AND COMPOUNDS FOR MOLECULAR IMAGING AND/OR RADIOIMMUNOTHERAPY
#9MOLECULAR PROBES FOR IN VIVO DETECTION OF ALDEHYDES
#10Chiral TACN/NOTA compounds/derivatives with and without metals for application
#11NEMO COILED COIL MIMICS AND METHODS OF USING SAME
#12METHOD FOR MANUFACTURING NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF AND MANUFACTURING INTERMEDIATE OF NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF
#13PSMA-TARGETING COMPOUNDS AND USES THEREOF
#14USE OF TRIAZOLE COMPOUND AS GHRELIN RECEPTOR AGONIST
#15COMPOUNDS FOR USE IN DIAGNOSIS AND/OR MONITORING OF FIBROSIS
#162-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD
#174-DIFLUOROMETHYL BENZOYL AMIDES WITH HERBICIDAL ACTION
#18SPIROUREA DERIVATIVES
#19TRIAZACYCLODODECANSULFONAMIDE (TCD)-BASED PROTEIN SECRETION INHIBITORS
#20NEMO COILED COIL MIMICS AND METHODS OF USING SAME
#21METHOD FOR SYNTHESIZING ZIRCONIUM COMPLEX
#22PSMA-targeting compounds and uses thereof
#23PSMA targeted fluorescent agents for image guided surgery
#24METAL COMPLEXES AND FLUORINATION THEREOF
#25TARGETING STAT SUMOYLATION TO ENHANCE IMMUNE RESPONSES
#26Triazacyclododecansulfonamide (“TCD”)-based protein secretion inhibitors
#27Nrf2 activating compounds and uses thereof
#28METHOD FOR MANUFACTURING NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF AND MANUFACTURING INTERMEDIATE OF NOVEL NITROGEN-CONTAINING COMPOUND OR SALT THEREOF
#29Nrf2 activating compounds and uses thereof
#30PSMA targeted fluorescent agents for image guided surgery
#31NEMO coiled coil mimics and methods of using same
#32PSMA TARGETED FLUORESCENT AGENTS FOR IMAGE GUIDED SURGERY
#334-DIFLUOROMETHYL BENZOYL AMIDES WITH HERBICIDAL ACTION
#34Multifunctional chelators, complexes, and compositions thereof, and methods of using same
#35METHOD FOR PREPARING NOTA DERIVATIVE
#36Disubstituted and trisubstituted 1,2,3-triazoles as Wnt inhibitors
#37Process for preparing polymers from monomers comprising laurolactam
#38LIBRARIES OF DIVERSE MACROCYCLIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME
#39Dimerization strategies and compounds for molecular imaging and/or radioimmunotherapy
#40Pre-targeting strategies for molecular imaging and/or radioimmunotherapy
#41Biguanide compositions and methods of treating metabolic disorders
#42Peptide thiourea derivative, radioisotope labeled compound containing same, and pharmaceutical composition containing same as active ingredient for treating or diagnosing prostate cancer
#43Methods for low temperature fluorine-18 radiolabeling of biomolecules
#44METHOD FOR PREPARING CONTRAST AGENT PRECURSOR
#45Nrf2 activating compounds and uses thereof
#46Charge-balanced imaging agents
#47Azasteroidal mimics
#48Substituted polycationic multi-quaternary ammonium salts as antimicrobial agents
#49Composition and method for scavenging sulfides and mercaptans
#50PSMA TARGETED FLUORESCENT AGENTS FOR IMAGE GUIDED SURGERY
#51Compositions and methods for treating metabolic disorders
#52Coating Composition Comprising an Alkyd-Comprising Resin and a Drier
#53CYSTATHIONINE-GAMMA-LYASE (CSE) INHIBITORS
#54Spiroacridine-triazine hybrids and applications for electroluminescent devices
#55Use of charge-balanced imaging agents for determining renal function
#56Charge-balanced imaging agents
#57Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other Molecules
#58PSMA TARGETED FLUORESCENT AGENTS FOR IMAGE GUIDED SURGERY
#59Nrf2 activating compounds and uses thereof
#60Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
#61Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions
#62Multifunctional chelators, complexes, and compositions thereof, and methods of using same
#63Macrocycles, cobalt and iron complexes of same, and methods of making and using same
#64Conjugates of 1,4,7-triazacyclononanes, dinuclear metal complexes of such conjugates, and methods of use for both 1,4,7-triazacyclononanes and conjugate
#65Synthesis of imidazo[1,2-a]pyrazin-4-ium salts for the synthesis of 1,4,7-triazacyclononane (tacn) and N- and/or C- functionalized derivatives thereof
#66Substituted imidazo ring systems and methods
#67Labeled alginate conjugates for molecular imaging applications
#68Compositions and methods for treating metabolic disorders
#69Metal complexes and fluorination thereof
#70IDO inhibitors
#71Bimodal ligands with macrocyclic and acyclic binding moieties, complexes and compositions thereof, and methods of using
#72Lanthanide complexes comprising at least two betaine groups, which can be used as luminescent markers
#73Water-soluble complexing agents and corresponding lanthanide complexes
#74Amphiphilic derivatives of triazamacrocyclic compounds, products and compositions including same, and synthesis methods and uses thereof
#75STRUCTURES OF PROTEASOME INHIBITORS AND METHODS FOR SYNTHESIZING AND USE THEREOF
#76Cystathionine-γ-lyase (CSE) inhibitors
#77PYRIDOMYCIN BASED COMPOUNDS EXHIBITING AN ANTITUBERCULAR ACTIVITY
#78Charged-balanced imaging agents
#79Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
#80Dual-acting imidazole antihypertensive agents
#81Compounds and methods for inhibiting phosphate transport
#82AMINO ACID ANALOGUES AND METHODS FOR THEIR SYNTHESIS
#83Labeled alginate conjugates for molecular imaging applications
#84PSMA-targeting compounds and uses thereof
#85Radiolabeled prostate specific membrane antigen inhibitors
#86Dual-acting antihypertensive agents
#87Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
#88GLP-1 receptor modulators
#89Macrocyclic compounds for modulating IL-17
#90Biguanide compositions and methods of treating metabolic disorders
#91Complexing agents and corresponding lanthanide complexes
#92Dual-acting imidazole antihypertensive agents
#93Aza metal complexes
#94Substituted imidazo ring systems and methods
#95Chemical compounds
#96Synthesis of imidazo[1,2-a]pyrazin-4-ium salts for the synthesis of 1,4,7-triazacyclononane (tacn) and N- and/or C-functionalized derivatives thereof
#97Conjugates of 1,4,7-triazacyclononanes, dinuclear metal complexes of such conjugates, and methods of use for both 1,4,7-triazacyclononanes and conjugates
#98Intermediates for preparing dual-acting benzyl triazole antihypertensive agents having angiotensin II type I receptor antagonist activity and neprilysin-inhibition activity
#99Triazanonane derivatives or pharmaceutically acceptable salt thereof for enhanced fluorine-18 labeling
#100Synthesis of therapeutic and diagnostic drugs centered on regioselective and stereoselective ring opening of aziridinium ions
#1011,2-bis-(4,7-dimethyl-1,4,7-triazacyclonon-1-yl)-ethane and intermediate for the synthesis of same
#102Heterocyclic derivative and pharmaceutical composition comprising the same
#103Compositions and methods of treating metabolic disorders
#104Lipomacrocycles and uses thereof
#105Cyclized peptidomimetic small molecule inhibitors of the WDR5 and MLL1 interaction
#106Labeled alginate conjugates for molecular imaging applications
#107Dual-acting benzyl triazole antihypertensive agents having angiotensin II type receptor antagonist activity and neprilysin-inhibition activity
#108Biguanide compositions and methods of treating metabolic disorders
#109Radiolabeled prostate specific membrane antigen inhibitors
#110Method for preparing (R)-3-(3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4(1H)-yl)phenyl)-5-(substituted methyl)oxazolidin-2-one derivatives
#111MICROCHEMICAL NANOFACTORIES
#112MACROCYCLIC COMPOUNDS, COMPOSITIONS COMPRISING THEM AND METHODS FOR PREVENTING OR TREATING HIV INFECTION
#113Dual-acting antihypertensive agents
#114Compound having heterocyclic ring
#115Dual-acting imidazole antihypertensive agents
#116Cyclic energetic nitramines desensitized with linear nitramines
#117Conjugates of 1,4,7-triazacyclononanes, dinuclear metal complexes of such conjugates, and methods of use for both 1,4,7-triazacyclononanes and conjugates
#118HETEROCYCLE-AMINO ACID DERIVATIVES FOR TARGETING CANCER TISSUE AND RADIOACTIVE OR NON-RADIOACTIVE LABELED COMPOUNDS THEREOF
#119Charged-balanced imaging agents
#120USE OF BUFFERS FOR RADIONUCLIDE COMPLEXATION
#121PSMA-targeting compounds and uses thereof
#122Dual-acting antihypertensive agents
#123Process for the manufacture of epichlorohydrin
#124Process for production of polymers with iron complex catalyst
#125Dual-acting imidazole antihypertensive agents
#126Linear and cyclic guanidine derivatives, method of preparation and uses thereof
#127MACROCYCLIC METAL COMPLEXES FOR THEIR USE AS ANTICANCER AGENTS
#128AZA compounds and production method thereof, and metal complexes as MRI contrast agents
#129Bimodal ligands with macrocyclic and acyclic binding moieties, complexes and compositions thereof, and methods of using
#130Compositions and Methods For The Treatment and Prevention of Disease
#131Chelating agents of metal ions, their methods of preparation and their applications
#132CLEAVAGE AGENT SELECTIVELY ACTING ON SOLUBLE ASSEMBLY OF AMYLOIDOGENIC PEPTIDE OR PROTEIN
#133Compound having heterocyclic ring
#134Peptide turn mimetics
#135Biomolecule labeling reactants based on azacycloalkanes and conjugates derived thereof
#136Modified Amino Acids
#137Triaza Compound Immunoregulatory Agents
#138Dual-acting imidazole antihypertensive agents
#139Dual-acting antihypertensive agents
#140Microchemical nanofactories
#141Compositions and methods for synthesizing heterocyclic therapeutic compounds
#142Compositions and methods for the inhibition of phospholipase A2
#143Compositions and methods for the treatment and prevention of disease
#144Benzotriazepine derivatives and their use as gastrin and cholecystokinin receptor ligands
#145Substituted imidazo ring systems and methods
#146Cyclic polyamine compounds for cancer therapy
#147Scorpionate-like pendant macrocyclic ligands, complexes and compositions thereof, and methods of using same
#148Triazacyclononane derivatives substituted on at least one of the nitrogen atoms with a substituted or unsubstituted 4'-aminophenyl group, for dyeing keratin fibres